Table 4. Clinical characteristics of patients at discharge.
| All patients (n=138) | Patients with USH (n=51) | Patients without USH (n=87) | |
|---|---|---|---|
| NYHA class | |||
| 1 | 72 (52) | 17 (33) | 55 (63) |
| 2 | 44 (32) | 23 (45) | 21 (24) |
| 3 | 21 (15) | 10 (20) | 11 (13) |
| 4 | 1 (1) | 1 (2) | 0 (0) |
| Ejection fraction (n=125) | |||
| ≥0.6 | 83 (66) | 32 (70) | 51 (65) |
| <0.6 | 42 (34) | 14 (30) | 28 (35) |
| BNP (n=122) | 64 (5.8-1300) | 96 (5.8-1300) | 51 (11-636) |
| Medication | |||
| Diuretics | 88 (64) | 42 (82) | 46 (53) |
| Beta blocker | 39 (28) | 15 (29) | 24 (28) |
| ACEI/ARB | 39 (28) | 16 (31) | 23 (26) |
| Anticoagulant | 65 (47) | 26 (51) | 39 (45) |
| Digitalis | 43 (31) | 22 (43) | 21 (24) |
| Antiarrhythmic | 45 (32) | 15 (29) | 30 (34) |
Values are n (%), or median (range). NYHA: New York Heart Association, BNP: B type natriuretic peptide, ACEI: angiotensin converting enzyme inhibitor, ARB: angiotensin II receptor blocker